European Neuroendocrine Tumour Society (ENETS) 2023 guidance paper for nonfunctioning pancreatic neuroendocrine tumours
Published 2023 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
European Neuroendocrine Tumour Society (ENETS) 2023 guidance paper for nonfunctioning pancreatic neuroendocrine tumours
Authors
Keywords
-
Journal
JOURNAL OF NEUROENDOCRINOLOGY
Volume -, Issue -, Pages -
Publisher
Wiley
Online
2023-10-05
DOI
10.1111/jne.13343
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Prediction of R Status in Resections for Pancreatic Cancer Using Simplified Radiological Criteria
- (2022) Louisa Bolm et al. ANNALS OF SURGERY
- Update on the clinical management of multiple endocrine neoplasia type 1
- (2022) Carolina R. C. Pieterman et al. CLINICAL ENDOCRINOLOGY
- Comparative outcomes of pancreatic neuroendocrine neoplasms: A population-based analysis of the SEER database
- (2022) Zhen Yang et al. EJSO
- Efficacy and safety of 177Lu‑DOTATATE in patients with advanced pancreatic neuroendocrine tumours: data from the NETTER-R international, retrospective study
- (2022) Dominique Clement et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Association of Upfront Peptide Receptor Radionuclide Therapy With Progression-Free Survival Among Patients With Enteropancreatic Neuroendocrine Tumors
- (2022) Sara Pusceddu et al. JAMA Network Open
- A Single-Center Prospective Observational Study Investigating the Accuracy of Preoperative Diagnostic Procedures in the Assessment of Lymph Node Metastases in Nonfunctioning Pancreatic Neuroendocrine Tumors
- (2022) Stefano Partelli et al. ANNALS OF SURGERY
- A randomized study of temozolomide or temozolomide and capecitabine in patients with advanced pancreatic neuroendocrine tumors: Final analysis of efficacy and evaluation of MGMT (ECOG-ACRIN E2211).
- (2022) Pamela L. Kunz et al. JOURNAL OF CLINICAL ONCOLOGY
- The evolution of PRRT for the treatment of neuroendocrine tumors; What comes next?
- (2022) Philip E. Harris et al. Frontiers in Endocrinology
- Portal vein resection during pancreaticoduodenectomy for pancreatic neuroendocrine tumors. An international multicenter comparative study
- (2021) Giuseppe K. Fusai et al. SURGERY
- The Safety and Efficacy of the Repeated PRRT with [90Y]Y/[177Lu]Lu-DOTATATE in Patients with NET
- (2021) Anna Zemczak et al. International Journal of Endocrinology
- Consensus on molecular imaging and theranostics in neuroendocrine neoplasms
- (2021) Valentina Ambrosini et al. EUROPEAN JOURNAL OF CANCER
- Surgical feasibility, Determinants and overall Efficacy assessment of Neoadjuvant PRRT with 177Lu-DOTATATE for Locally Advanced Unresectable Gastroenteropancreatic Neuroendocrine Tumors
- (2021) Rahul V Parghane et al. JOURNAL OF NUCLEAR MEDICINE
- Semi-automatic tumor delineation for evaluation of 64Cu-DOTATATE PET/CT in patients with neuroendocrine neoplasms: prognostication based on lowest lesion uptake and total tumor volume
- (2021) Esben Andreas Carlsen et al. JOURNAL OF NUCLEAR MEDICINE
- High vimentin expression with E-cadherin expression loss predicts a poor prognosis after resection of grade 1 and 2 pancreatic neuroendocrine tumors
- (2021) Bo Zhou et al. BMC CANCER
- A multigenomic liquid biopsy biomarker for neuroendocrine tumor disease outperforms CgA and has surgical and clinical utility
- (2021) I.M. Modlin et al. ANNALS OF ONCOLOGY
- Reconsideration of Clinicopathologic Prognostic Factors in Pancreatic Neuroendocrine Tumors for Better Determination of Adverse Prognosis
- (2021) Anil Aysal et al. ENDOCRINE PATHOLOGY
- International Validation of a Nomogram to Predict Recurrence after Resection of Grade 1 and 2 Non-Functioning Pancreatic Neuroendocrine Tumors
- (2021) Charlotte M. Heidsma et al. NEUROENDOCRINOLOGY
- Temozolomide in Grade 3 Gastroenteropancreatic Neuroendocrine Neoplasms: A Multicenter Retrospective Review
- (2021) David L. Chan et al. ONCOLOGIST
- The Impact of 68Gallium DOTA PET/CT in Managing Patients With Sporadic and Familial Pancreatic Neuroendocrine Tumours
- (2021) Daniel J. Cuthbertson et al. Frontiers in Endocrinology
- Efficacy and safety of high-dose lanreotide autogel in patients with progressive pancreatic or midgut neuroendocrine tumours: CLARINET FORTE phase 2 study results
- (2021) Marianne Pavel et al. EUROPEAN JOURNAL OF CANCER
- Belzutifan for Renal Cell Carcinoma in von Hippel–Lindau Disease
- (2021) Eric Jonasch et al. NEW ENGLAND JOURNAL OF MEDICINE
- A meta-analysis of the accuracy of a neuroendocrine tumor mRNA genomic biomarker (NETest) in blood
- (2020) K. Öberg et al. ANNALS OF ONCOLOGY
- Impact of liver tumour burden, alkaline phosphatase elevation, and target lesion size on treatment outcomes with 177Lu-Dotatate: an analysis of the NETTER-1 study
- (2020) Jonathan Strosberg et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Outcomes after distal pancreatectomy for neuroendocrine neoplasms: a retrospective comparison between minimally invasive and open approach using propensity score weighting
- (2020) Stefano Partelli et al. SURGICAL ENDOSCOPY AND OTHER INTERVENTIONAL TECHNIQUES
- Gastroenteropancreatic neuroendocrine neoplasms: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
- (2020) M. Pavel et al. ANNALS OF ONCOLOGY
- Clues For Genetic Anticipation In Multiple Endocrine Neoplasia Type 1
- (2020) Medard F M van den Broek et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Prospective Evaluation of the NETest as a Liquid Biopsy for Gastroenteropancreatic and Bronchopulmonary Neuroendocrine Tumours: An ENETS Centre of Excellence Experience
- (2020) Anna Malczewska et al. NEUROENDOCRINOLOGY
- Peptide Receptor Radionuclide Therapy for the Treatment of Pancreatic Neuroendocrine Tumors: Recent Insights
- (2020) Jason S Starr et al. OncoTargets and Therapy
- Prognostic factors for the outcome of nonfunctioning pancreatic neuroendocrine tumors in MEN1: a systematic review of literature
- (2020) S M Sadowski et al. ENDOCRINE-RELATED CANCER
- 18F-FDG-PET is superior to WHO grading as prognostic tool in neuroendocrine neoplasms and useful in guiding peptide receptor radionuclide therapy: a prospective 10-year follow-up study of 166 patients
- (2020) Tina Binderup et al. JOURNAL OF NUCLEAR MEDICINE
- Somatostatin Analogs for Pancreatic Neuroendocrine Tumors: Any Benefit When Ki‐67 Is ≥10%?
- (2020) Elettra Merola et al. ONCOLOGIST
- Peptide receptor radiotherapy re-treatment in patients with progressive neuroendocrine tumors: A systematic review and meta-analysis
- (2020) Jonathan Strosberg et al. CANCER TREATMENT REVIEWS
- Temozolomide alone or combined to capecitabine for the treatment of advanced pancreatic NET
- (2019) Louis de Mestier et al. NEUROENDOCRINOLOGY
- A Novel Validated Recurrence Risk Score to Guide a Pragmatic Surveillance Strategy After Resection of Pancreatic Neuroendocrine Tumors
- (2019) Mohammad Y. Zaidi et al. ANNALS OF SURGERY
- Multi-institutional Development and External Validation of a Nomogram to Predict Recurrence After Curative Resection of Pancreatic Neuroendocrine Tumors
- (2019) Alessandra Pulvirenti et al. ANNALS OF SURGERY
- The 2019 WHO classification of tumours of the digestive system
- (2019) Iris D. Nagtegaal et al. HISTOPATHOLOGY
- Prediction of Progression-Free Survival in Patients With Advanced, Well-Differentiated, Neuroendocrine Tumors Being Treated With a Somatostatin Analog: The GETNE-TRASGU Study
- (2019) Alberto Carmona-Bayonas et al. JOURNAL OF CLINICAL ONCOLOGY
- Peritoneal carcinomatosis in gastro-entero-pancreatic neuroendocrine neoplasms: clinical impact and effectiveness of the available therapeutic options
- (2019) ELETTRA MEROLA et al. NEUROENDOCRINOLOGY
- Prospective study of chromogranin A as a predictor of progression in patients with pancreatic, small intestinal and unknown primary neuroendocrine tumors.
- (2019) Gitte Dam et al. NEUROENDOCRINOLOGY
- The clinical applications of a multigene liquid biopsy (NETest) in neuroendocrine tumors
- (2019) Anna Malczewska et al. Advances in Medical Sciences
- Immunohistochemistry in the diagnosis and classification of neuroendocrine neoplasms: what can brown do for you?
- (2019) Andrew M Bellizzi HUMAN PATHOLOGY
- Tumor burden score predicts tumor recurrence of non-functional pancreatic neuroendocrine tumors after curative resection
- (2019) Ding-Hui Dong et al. HPB
- Contrast harmonic EUS for the prediction of pancreatic neuroendocrine tumor aggressiveness (with videos)
- (2018) Maxime Palazzo et al. GASTROINTESTINAL ENDOSCOPY
- Clinical and Biomarker Evaluations of Sunitinib in Patients with Grade 3 Digestive Neuroendocrine Neoplasms
- (2018) Anna Pellat et al. NEUROENDOCRINOLOGY
- Peptide receptor radionuclide therapy as neoadjuvant therapy for resectable or potentially resectable pancreatic neuroendocrine neoplasms
- (2018) Stefano Partelli et al. SURGERY
- 68Ga PET Imaging in Patients With Neuroendocrine Tumors
- (2018) Simron Singh et al. CLINICAL NUCLEAR MEDICINE
- Peptide Receptor Radionuclide Therapy in Grade 3 Neuroendocrine Neoplasms: Safety and Survival Analysis in 69 Patients
- (2018) Jingjing Zhang et al. JOURNAL OF NUCLEAR MEDICINE
- Patterns of recurrence after resection for pancreatic neuroendocrine tumors: who, when, and where?
- (2018) Giovanni Marchegiani et al. NEUROENDOCRINOLOGY
- Peptide receptor radionuclide therapy in gastroenteropancreatic NEN G3: a multicenter cohort study
- (2018) Esben Andreas Carlsen et al. ENDOCRINE-RELATED CANCER
- Safety of multiple repeated cycles of 177Lu-octreotate in patients with recurrent neuroendocrine tumour
- (2017) Anna Yordanova et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Peptide receptor radionuclide therapy (PRRT) in European Neuroendocrine Tumour Society (ENETS) grade 3 (G3) neuroendocrine neoplasia (NEN) - a single-institution retrospective analysis
- (2017) Sue Ping Thang et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Neuroendocrine liver metastases: Vascular patterns on triple-phase MDCT are indicative of primary tumour location
- (2017) Maxime Ronot et al. EUROPEAN JOURNAL OF RADIOLOGY
- National Rise of Primary Pancreatic Carcinoid Tumors: Comparison to Functional and Nonfunctional Pancreatic Neuroendocrine Tumors
- (2017) Gyulnara G. Kasumova et al. JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS
- Whole-genome landscape of pancreatic neuroendocrine tumours
- (2017) Aldo Scarpa et al. NATURE
- ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Tumors: Radiological, Nuclear Medicine and Hybrid Imaging
- (2017) Anders Sundin et al. NEUROENDOCRINOLOGY
- ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Tumors: Pathology - Diagnosis and Prognostic Stratification
- (2017) Aurel Perren et al. NEUROENDOCRINOLOGY
- Everolimus in Pancreatic Neuroendocrine Carcinomas G3
- (2017) Francesco Panzuto et al. PANCREAS
- Gastroenteropancreatic neuroendocrine tumors: impact of consistent contrast agent selection on radiologists’ confidence in hepatic lesion assessment on restaging MRIs
- (2017) Patricia Balthazar et al. Abdominal Radiology
- Trends in the Incidence, Prevalence, and Survival Outcomes in Patients With Neuroendocrine Tumors in the United States
- (2017) Arvind Dasari et al. JAMA Oncology
- Utility of chromogranin A, pancreatic polypeptide, glucagon and gastrin in the diagnosis and follow-up of pancreatic neuroendocrine tumours in multiple endocrine neoplasia type 1 patients
- (2016) Wei Qiu et al. CLINICAL ENDOCRINOLOGY
- Evaluation of Magnetic Resonance (MR) Biomarkers for Assessment of Response With Response Evaluation Criteria in Solid Tumors
- (2016) Gustavo Felipe Luersen et al. JOURNAL OF COMPUTER ASSISTED TOMOGRAPHY
- Head-to-Head Comparison of 64 Cu-DOTATATE and 68 Ga-DOTATOC PET/CT: A Prospective Study of 59 Patients with Neuroendocrine Tumors
- (2016) Camilla B. Johnbeck et al. JOURNAL OF NUCLEAR MEDICINE
- Not All Patients with a Pancreatic Neuroendocrine Tumour Will Benefit from All Approved or Recommended Therapeutic Options: A Real-Life Retrospective Study
- (2016) Amandine Berdelou et al. NEUROENDOCRINOLOGY
- ENETS Consensus Guidelines Update for the Management of Patients with Functional Pancreatic Neuroendocrine Tumors and Non-Functional Pancreatic Neuroendocrine Tumors
- (2016) M. Falconi et al. NEUROENDOCRINOLOGY
- Imaging Tests for the Diagnosis and Staging of Pancreatic Adenocarcinoma
- (2016) Jonathan R. Treadwell et al. PANCREAS
- Efficacy of endoscopic ultrasonography and endoscopic ultrasonography-guided fine-needle aspiration for the diagnosis and grading of pancreatic neuroendocrine tumors
- (2015) Nao Fujimori et al. SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY
- Lanreotide in Metastatic Enteropancreatic Neuroendocrine Tumors
- (2014) Martyn E. Caplin et al. NEW ENGLAND JOURNAL OF MEDICINE
- Evaluation of radiological prognostic factors of hepatic metastases in patients with non-functional pancreatic neuroendocrine tumors
- (2013) Timm Denecke et al. EUROPEAN JOURNAL OF RADIOLOGY
- Loss of DAXX and ATRX Are Associated With Chromosome Instability and Reduced Survival of Patients With Pancreatic Neuroendocrine Tumors
- (2013) Ilaria Marinoni et al. GASTROENTEROLOGY
- ISL1 expression is not restricted to pancreatic well-differentiated neuroendocrine neoplasms, but is also commonly found in well and poorly differentiated neuroendocrine neoplasms of extrapancreatic origin
- (2013) Abbas Agaimy et al. MODERN PATHOLOGY
- High Sensitivity of Diffusion-weighted MR Imaging for the Detection of Liver Metastases from Neuroendocrine Tumors: Comparison with T2-weighted and Dynamic Gadolinium-enhanced MR Imaging
- (2013) Gaspard d’Assignies et al. RADIOLOGY
- Molecular pathology and genetics of pancreatic endocrine tumours
- (2012) Gabriele Capurso et al. JOURNAL OF MOLECULAR ENDOCRINOLOGY
- Metastatic and Locally Advanced Pancreatic Endocrine Carcinomas: Analysis of Factors Associated With Disease Progression
- (2011) Francesco Panzuto et al. JOURNAL OF CLINICAL ONCOLOGY
- Sunitinib Malate for the Treatment of Pancreatic Neuroendocrine Tumors
- (2011) Eric Raymond et al. NEW ENGLAND JOURNAL OF MEDICINE
- Everolimus for Advanced Pancreatic Neuroendocrine Tumors
- (2011) James C. Yao et al. NEW ENGLAND JOURNAL OF MEDICINE
- DAXX/ATRX, MEN1, and mTOR Pathway Genes Are Frequently Altered in Pancreatic Neuroendocrine Tumors
- (2011) Y. Jiao et al. SCIENCE
- First-line chemotherapy with capecitabine and temozolomide in patients with metastatic pancreatic endocrine carcinomas
- (2010) Jonathan R. Strosberg et al. CANCER
- Ki-67 index, tumor differentiation, and extent of liver involvement are independent prognostic factors in patients with liver metastases of digestive endocrine carcinomas
- (2010) O. Hentic et al. ENDOCRINE-RELATED CANCER
- Prognostic Score Predicting Survival After Resection of Pancreatic Neuroendocrine Tumors
- (2009) Karl Y. Bilimoria et al. ANNALS OF SURGERY
- Asymptomatic Children with Multiple Endocrine Neoplasia Type 1 Mutations May Harbor Nonfunctioning Pancreatic Neuroendocrine Tumors
- (2009) Paul J. Newey et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)
- (2008) E.A. Eisenhauer et al. EUROPEAN JOURNAL OF CANCER
- GRADE: an emerging consensus on rating quality of evidence and strength of recommendations
- (2008) Gordon H Guyatt et al. BMJ-British Medical Journal
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started